On June 9, 2025, HHS removed all members of the CDC’s vaccine advisory committee (ACIP), citing the need to restore public trust and eliminate conflicts of interest. Learn what this change could mean for healthcare payers, providers, and immunization policy in the U.S.
Federal agencies have amplified efforts to enforce healthcare price transparency, introducing stringent guidelines and escalating penalties to ensure compliance. These regulatory updates affect hospitals, insurers, and employers nationwide and demand immediate attention and action to remain compliant.
The FDA has approved the first at-home cervical cancer screening kit, the Teal Wand™, offering a self-administered alternative to Pap smears.
OpenAI has introduced HealthBench, a groundbreaking benchmark designed to assess the performance and safety of AI systems in healthcare settings.
Health Policy in 2025: Key Updates Impacting Payers and Administrators At A Glance A series of pivotal health policy shifts in early 2025 are reshaping
The FDA has approved Google’s Pixel Watch 3 for loss-of-pulse detection, marking a major step in wearable health tech.
On February 25, 2025, the Trump administration announced an Executive Order focused on enhancing price transparency in healthcare, a critical step toward empowering patients with clear and actionable pricing information. This initiative is expected to foster competition among providers and payers, ultimately aiming to reduce healthcare costs and improve patient access to care.
Could AI soon prescribe medications? H.R. 238 raises crucial questions about the role of artificial intelligence in healthcare decision-making.
